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Use of Drug-Eluting Stent with Provisional T-Stenting Technique 
in the Treatment of Renal Artery Bifurcation Stenosis; Long-term 
Angiographic Follow-up
Atherosclerotic renal artery stenosis (RAS) usually involves the ostium and the proximal 
one-third of the renal artery main branch. Percutaneous renal artery angioplasty with stent 
placement is a well recognized treatment for atherosclerotic RAS. Occasionally, 
atherosclerotic RAS involves renal artery bifurcations. However, stent implantation in 
atherosclerotic RAS involving bifurcation is not only troublesome, but also challenging 
because of side branch occlusion and in-stent restenosis (ISR). In the present report, we 
describe the use of drug-eluting stents (DES) with provisional T-stenting technique for the 
treatment of renal artery bifurcation lesion. Follow-up angiogram showed no significant 
ISR 18 months after the procedure. In the treatment of renal bifurcation lesions, a two-
stent strategy using DES could be a viable option in selected patients.
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CASE REPORT
Cardiovascular Disorders
INTRODUCTION
Renal artery stenosis (RAS) is a progressive disease that may cause 
hypertension and chronic renal insufficiency. Percutaneous re-
nal artery angioplasty with stent placement is a well recognized 
treatment for ostial and proximal RAS. Infrequently, atheroscle-
rotic RAS can involve bifurcation of the renal artery, making treat-
ment of this stenosis difficult and challenging (1). One challenge 
in interventional therapy for RAS with bifurcation is avoiding 
side branch occlusion; techniques developed in percutaneous 
coronary intervention might be used in this situation. When 
side branch occlusion occurs during renal artery intervention, 
two-stenting techniques might be useful. Another challenge is 
ISR. Prvious prospective nonrandomized trial couldn’t support 
the role of DES in the treatment of RAS (2). However, if using an 
adequate sized DES and valid techniques, we considered DES 
as a possible solution. In the present report, we describe the use 
of DES with provisional T-stenting technique for the treatment 
of renal artery bifurcation lesion. In our patient, a follow-up an-
giogram showed no significant ISR 18 months after the proce-
dure.
CASE DESCRIPTION
A 66-yr-old man with history of hypertension, diabetes mellitus, 
and atrial fibrillation was hospitalized for evaluation of chest 
pain and control of resistant hypertension on 17 July, 2009. De-
spite pharmacologic therapy of nebivolol (10 mg daily), amlo-
dipine (5 mg daily), and hydrochlorothiazide (25 mg daily), his 
blood pressure remained elevated in the range of 180-190/70-90 
mmHg. The creatinine was within the normal range (1.1 mg/dL). 
Coronary angiography was performed for evaluation of chest 
pain. The test revealed 80% stenosis of the proximal left circum-
flex artery and diffuse stenosis of the proximal to mid-right cor-
onary artery followed by coronary stenting with the left circum-
flex artery and the right coronary artery. Subsequent to the eval-
uation of the resistant hypertension, a renal angiography was 
obtained, which revealed a nonvisualized left kidney and severe 
stenosis of the right renal artery bifurcation involving both branch-
es (Fig. 1A). Contrast-enhanced abdominal computed tomog-
raphy demonstrated atrophic change of the left kidney and ste-
nosis of the right renal artery. On the 4th day of admission, the 
decision was made to treat the stenosis of the right renal artery 
bifurcation. An 8 Fr renal double curve (RDC) catheter (Boston 
Scientific, Natic, MA, USA) was positioned at the ostium of the 
right renal artery. Two 0.014-inch reflex upper soft wires (Cor-
dis, Miami Lakes, FL, USA) were then placed into each branch 
vessel of the main renal artery. Kissing balloon angioplasty of 
the bifurcation was performed using appropriately sized bal-
loons. After the angioplasty, a 7.0 × 24 mm Genesis stent (Cor-Ahn J, et al.  •  DES in Renal Artery Bifurcation Stenosis
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dis, Miami Lakes, FL, USA) was deployed into the main branch 
(upper pole). This resulted in a “snowplowing” effect, shifting 
plaque to the side branch (lower pole). A 3.5 × 12 mm PROMUS 
stent (Boston Scientific, Galway, Ireland) was then deployed into 
the side branch using provisional T-stenting technique (Fig. 1B). 
Finally, the main branch was post-dilated with a 6.0 × 12 mm 
ultrasoft SV balloon (Boston scientific, Natic, MA, USA) at 18 atm, 
and the side branch was post-dilated with a 3.5 × 12 mm Sprinter 
legend balloon (Medtronic, Minapolis, MN, USA) at 18 atm in a 
kissing fashion. An angiogram after stent placement demon-
strated widely patent bifurcational stents with normal flow pa-
tency (Fig. 1C). Blood pressure was well controlled and the pa-
tient was discharged in stable condition. After 18 months, a fol-
low-up angiogram showed mild stenosis in the main branch 
and the side branch ostium (Fig. 1D). Because the blood pres-
sure was well controlled and lumen diameter loss was less than 
30%, the lesion was not treated. 
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Fig. 1. Renal angiogram of the patient. (A) Significant stenosis at right renal artery bifurcation. (B) Deployment of Genesis stent at main branch and PROMUS stent at side branch 
using provisional T-stenting technique. (C) After stent placement revealing a patent renal artery with no residual stenosis. (D) Follow-up angiogram showing 20% mild stenosis 
in main branch and minimal stneosis in side branch.Ahn J, et al.  •  DES in Renal Artery Bifurcation Stenosis
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DISCUSSION
Atherosclerotic RAS is most often caused by plaque formation 
in the aortic wall with progression into the renal artery lumen, 
thereby inducing the typical appearance of the ostial (first 2 cm), 
usually eccentric, location of the lesion (3). These lesions are of-
ten elastic and respond poorly to balloon angioplasty alone, re-
sulting in significant residual stenosis and restenosis (4). With 
the introduction of balloon-expandable metallic stents, a new 
treatment became available with improved post-interventional 
results and lower restenosis rates by preventing negative remod-
eling. In a meta-analysis of 1,322 patients, stent placement had 
a higher technical success rate and a lower restenosis rate than 
percutaneous transluminal renal angioplasty (5).
  Renal artery stenosis involving bifurcation is not seen in the 
majority of clinical practices and, as a result, experience in treat-
ing renal artery bifurcation is limited (6). When treating bifurca-
tion lesions, stent implantation in only one branch can result in 
obstruction of the remaining branch. Bifurcation lesions are fre-
quent in coronary arteries, and treatment with a stent is com-
mon even though it is difficult (7). Studies from the bare-metal 
stent (BMS) era consistently demonstrated that the one-stent 
approach was superior to the two-stent approach; this view re-
mains controversial in the DES era (8). Although two-stent strat-
egy has not been proven to be superior in the treatment of coro-
nary arteries, this might not be true in renal artery stenosis. Be-
cause the size of the renal artery is usually larger than the coro-
nary artery, when abrupt closure of a side branch occurs, stent-
ing becomes necessary to preserve branch patency. In our case, 
main branch stenting resulted in side branch occlusion, and the 
diameter of the side branch was not small enough (3.5 mm) to 
scarify. Therefore, we decided to treat the lesion with two-stent-
ing strategy.
  Another problem is in-stent restenosis (ISR). Restenosis rates 
after successful renal stent placement vary from 6% up to 40% 
depending on the definition of restenosis, which is still contro-
versial in the DES era (9). In the GREAT trial, ISR, late lumen loss, 
and repeat revascularization after renal artery stent implanta-
tion were lower in the sirolimus-eluting stent group than in the 
BMS group, but the difference was not statistically significant 
(2). However, in the GREAT trial, only 5 and 6 mm stents were 
used in the study. Some of the treated arteries in both patient 
groups were larger in diameter than 6mm, and under-stenting 
might have influenced the outcome. Usually, ISR rates in small 
renal arteries are much higher than those in other renal arter-
ies. We determined that if we could size the stent diameter at a 
ratio of 1.0-1.1:1 to the distal reference diameter, DES might re-
duce the occurrence of restenosis, as has been demonstrated in 
coronary arteries. In our case, the reference diameter of the side 
branch was 3.5 mm, so we were able to use an adequately sized 
drug-eluting stent (PROMUS, Boston Scientific).
  There are limited data on the use of DES in renal arteries for 
the treatment of complex stenosis involving bifurcation lesion. 
To the best of our knowledge, this is the first reported case of 
“provisional T-stenting” using DES for bifurcation lesions in the 
renal artery with documented good long-term (18 months) an-
giographic outcome. In the treatment of renal bifurcation le-
sions, a two-stent strategy using DES could be a viable option in 
selected patients.
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